BioSpace News Archive

LifeCare returns to its roots in critical care with the purchase of four specialty hospitals and reimagining of its brand.

Silicon Valley-based medical device company PQ Bypass announced today the 100th patient in the DETOUR2 Clinical Trial, which evaluates the safety and effectiveness of the minimally invasive DETOUR procedure for percutaneous femoropopliteal bypass.

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced a strategic outlook for 2020 outlining key priorities for its broad pipeline.

Veeva Systems (NYSE:VEEV) today announced that Paul Shawah, SVP of Veeva Commercial Cloud, will present at the 38th annual J.P. Morgan Healthcare Conference on Thursday, Jan 16, 2020, at 10:00 a.m. Pacific Time in San Francisco.

The Dental Solutions Company, announced it will participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 in San Francisco..

Companion Medical, Inc. announced that it has entered into a loan and security agreement for up to $27.5 million with K2 HealthVentures, a healthcare-focused specialty finance company.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, will release results on Monday, January 13, 2020 at 5.00 am GMT from a Phase 2b dose-ranging study evaluating nebulized ensifentrine as an add-on to treatment with a long acting bronchodilator in patients with moderate-to-severe COPD.

InMed Pharmaceuticals Inc. confirmed that at its annual general meeting of shareholders held on December 19, 2019, all directors nominated as listed in the information circular dated November 7, 2019 were elected as directors of the Company for the ensuing year.

Medable Inc., the end-to-end platform for digitally enabled and data-driven clinical trials, announced that Andrea Sanchez, Vice President Legal & SaMD secured CIPP/E Certification.